Asia Pacific Antimicrobial Surgical Suture Market Report by Scope, Segmentation, Dynamics, and Competitive Analysis

The Asia Pacific antimicrobial surgical suture market size is expected to reach US$ 124.73 million by 2031 from US$ 51.68 million in 2023. The market is estimated to record a CAGR of 11.7% from 2024-2031.

Executive Summary and Asia Pacific Antimicrobial Surgical Suture Market Analysis:

The Asia Pacific antimicrobial surgical suture market is further segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. This region is the fastest-growing market for antimicrobial surgical sutures in global scenarios. Asia Pacific is expected to witness the highest growth over the forecast period.

The antimicrobial surgical suture market in this region is expected to grow owing to factors such as rising plastic surgeries and increasing demand for medical tourism in emerging economies such as China and India. Moreover, the increase in the number of research studies and the surge in healthcare expenditure are anticipated to fuel the market growth during the forecast period.

Asia Pacific Antimicrobial Surgical Suture Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.

Based on type, the Asia Pacific antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.

By raw materials, the Asia Pacific antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.

By application, the Asia Pacific antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynaecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.

By end user, the Asia Pacific antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.

Asia Pacific Antimicrobial Surgical Suture Market Outlook

The RMIT Centre for Materials Innovation and Future Fashion is one of the organizations focusing on developing new, smart antimicrobial sutures to reduce the prevalence of surgical site infections. The center's suture products are made from materials that glow during medical imaging procedures; these stitches have the potential to replace mesh implants as promising alternatives. They can be beneficial in monitoring patient recovery progress, in addition to their impressive antimicrobial properties, preventing infections and killing 99% of highly drug-resistant bacteria after 6 hours of contact at body temperature. It may also significantly reduce surgery duration and increase surgical accuracy in general through the ability to visualize mesh location accurately on preoperative imaging.

MIT engineers have created 'smart' sutures that can not only hold tissues in place but also sense inflammation and deliver drugs. The new sutures are made from animal tissue, similar to the 'catgut' sutures created by the ancient Romans. These sutures are coated with hydrogels that can be integrated with sensors, drugs, or even cells that release therapeutic substances. These sutures could be particularly beneficial for the treatment of Crohn's disease patients who need to undergo colectomy due to excessive scarring or inflammation. MIT's smart sutures hold the tissue in place and identify inflammation as an early warning sign indicating the improper functioning of the resealed intestines. The hydrogel coating of these sutures carries drugs through microparticles composed of FDA-approved polymers such as PLA and PLGA, which also aid in a controlled drug release rate. This approach could also be used to deliver other drugs, such as chemotherapy drugs or antibiotics. Therefore, developments in smart antimicrobial surgical sutures are expected to bring new growth trends in the antimicrobial surgical sutures market growth in the coming years.

Asia Pacific Antimicrobial Surgical Suture Market Country Insights

Based on country, the Asia Pacific antimicrobial surgical suture market comprises Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest share in 2023.

China performs more plastic surgery operations than any country except America. According to a report, over 22 million plastic surgeries were performed in China in 2020. This includes only the procedures performed by licensed plastic surgeons, which is likely higher due to the presence of unlicensed plastic surgeons in China. China's changing attitudes toward self-image, growing wealth, technological advancements, and obsession with celebrity culture fuel this growth. In China, beauty is deemed an advantage in the competitive mid-level workplace because job applicants are often required to submit a photograph with their application.

Apart from Plastic surgeries, orthopedic and general surgeries are also propelling the market for hospital sutures in China. In August 2020, Beijing Haidian Hospital officially introduced orthopedic surgery robots in May 2020 and completed more than 400 robotic surgeries by the end of August 2021. The orthopedic surgical robot could dynamically analyze the patient's anatomy and the spine-hip relation and carry out individualized surgery planning precisely as planned.

Asia Pacific Antimicrobial Surgical Suture Market Company Profiles

Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Futura Surgicare Pvt Ltd (Dolphin Sutures); Healthium Medtech Limited; Internacional Farmacéutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; and TI Medical among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Antimicrobial Surgical Suture Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report.

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

Company websites, annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents, statistical databases, and market reports. News articles, press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The publisher conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific antimicrobial surgical suture market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific antimicrobial surgical suture market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the antimicrobial surgical suture market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.